LEADER 03137nam 2200433 450 001 9910420947303321 005 20210225173427.0 010 $a3-319-95828-3 024 7 $a10.1007/978-3-319-95828-6 035 $a(CKB)4100000011476726 035 $a(MiAaPQ)EBC6360915 035 $a(DE-He213)978-3-319-95828-6 035 $a(PPN)250222442 035 $a(EXLCZ)994100000011476726 100 $a20210225d2020 uy 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aNon-alcoholic fatty liver disease $ea 360-degree overview /$fElisabetta Bugianesi, editor 205 $a1st ed. 2020. 210 1$aCham, Switzerland :$cSpringer,$d[2020] 210 4$dİ2020 215 $a1 online resource (X, 362 p. 45 illus., 41 illus. in color.) 311 $a3-319-95827-5 327 $aIntroduction -- Obesity and NAFLD: same problem? The burden of NAFLD worldwide -- Histo-pathology of NAFLD -- NAFLD and insulin resistance: a multisystemic -- Etiopathogenesis of NAFLD: diet, gut and NASH -- Etiopathogenesis of NAFLD: molecular mechanisms of fibrogenesis -- The natural history of NAFLD: Environmental vs Genetic Risk Factors -- NAFLD and endocrine disease: clinical implications -- NAFLD and Cardiovascular Disease: clinical implications -- NAFLD, Hepatocellular Carcinoma and extrahepatic cancers -- NAFLD in children: implications for the future -- Diagnostic algorithm for the identification of NAFLD in primary care -- Non-Invasive diagnostic approach to NASH: Biological Markers -- Non-Invasive diagnostic approach to NASH: Radiological Diagnostics -- Dietary approach to NAFLD -- Physical Activity in NAFLD: what and how much? Pharmacological Therapy of NASH -- Bariatric Surgery and NASH: a feasible option? Liver transplantation and NASH -- Unmet needs and future goals. 330 $aThe goal of this book is to promote awareness of non-alcoholic fatty liver disease (NAFLD) ? which is rapidly replacing viral hepatitis as the leading cause of chronic liver disease in Europe, North and South America and Asia ? and to share the latest information on evolving approaches to diagnosis and treatment. The book offers a comprehensive overview of the current topics of interest in the field, and provides clinical guidance on NAFLD through a multidisciplinary approach based on the latest scientific understanding of this multisystemic disease, involving the expertise of specialists including hepatologists, diabetologists, and cardiologists. The respective contributions address various aspects, including the newly released international guidelines, novel diagnostic modalities, and new experimental drugs. The work will appeal to a broad readership, from residents in internal medicine to specialists. 606 $aFatty liver 615 0$aFatty liver. 676 $a616.362 702 $aBugianesi$b Elisabetta 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910420947303321 996 $aNon-alcoholic fatty liver disease$92095512 997 $aUNINA